PTH and hyperuricemia: Hyperuricemia is a strong contributor to MBD; it is a very common condition in patients with CKD and is characterized by hyperphosphatemia, hypocalcemia, and elevated levels of PTH, which is associated with bone disease, vascular calcifications, and risk of all-cause and cardiovascular death [4,22,41].